Mab Designs publishes study on C20, a selective IL-6 trans-signalling inhibitor

Mab Designs has announced the publication of research on C20, a compound that selectively inhibits human IL-6 trans-signalling while preserving classic signalling pathways. This development is detailed in the journal Communications Biology, highlighting a targeted approach in modulating IL-6 activity.

Originally published by gnews